ArticleEMBO molecular medicine2025
De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.
Duo Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleEMBO molecular medicine2025
Duo Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.